Type To Search
Vcaps® Gen C Capsules
Building on our history of innovation in polymer science and capsule engineering, Capsugel, now a Lonza company, continues to launch ground-breaking capsule designs and equipment technologies that are improving drug development and delivery.
New Specialty Polymer Capsule
Vcaps® Gen C Capsules high-quality capsule for pharmaceutical products based on a carrageenan gelling agent formulation.
Continuing to pioneer specialty polymer capsules, the Capsugel® HPMC portfolio gets enriched with Vcaps® Gen C Capsules, advancing the ability of pharmaceutical manufacturers to qualify a high-performing gelling agent-based capsule, with the Capsugel® high quality and performance standards.
Robust Sourcing
Formulated to match current pharmaceutical products, aiming for a seamless qualification
Supports a dual sourcing strategy
Flawless functionality
Fast dissolution profile, pH independent without lag time, comparable to gelatin
Appealing looks, enabling patient acceptance and treatment compliance
Solid performance
High robustness
Suitable for moisture sensitive formulations
Consistent quality and machinability
Seamless Supply
Reliable global distribution chain
Widest and most flexible production capacity
Product Description
Manufactured with non-animal cellulose derivatives (HPMC)
Product formulation using carrageenan as gelling agent
Regulatory Status
- Contains established polymers used in pharmaceutical applications for more than 20 years
- Suitable for use in drug products marketed in major markets
Meeting the demand of pharmaceutical manufacturers
The addition of Capsugel® Vcaps® Gen C broadens the already comprehensive HPMC product portfolio, providing solutions for immediate and modified release dosage forms. This new member of the vegan family will help pharmaceutical customers bring products to market faster, reliably.